BackRubius Therapeutics Overview

Rubius Therapeutics Current Cash

Latest current cash for RUBY: $15M.

Get informed when a big investor buys or sells

+ Follow
Current Cash
$14.87M
↓ 93.42% YoYΔ $-210.98M vs prior year quarter

Peer trimmed avg / median

Loading

Rubius Therapeutics Current Cash History

Loading

Rubius Therapeutics vs. peers: Current Cash Comparison

Loading

Rubius Therapeutics Cash Growth (YoY per quarter)

Latest change versus the prior comparable period (same company).

Loading

Balance Sheet Breakdown

Current CashShort Term InvestmentsReceivablesInventoryOther Current AssetsCurrent AssetsLong Term InvestmentsProperty Plant EquipmentGoodwillIntangible AssetsOther AssetsTotal AssetsNet Tangible AssetsAccounts PayableOther Current LiabilitiesTotal Current LiabilitiesLong Term DebtOther LiabilitiesMinority InterestTotal Liabilities

Rubius Therapeutics (RUBY) FAQ

As of the most recent data (December 2022), RUBY shows a current cash of $15M. That compares with $230M in the prior-year period — down 93.4% year over year. Scroll down for historical charts and peer comparison views.

Compared with the year-ago period, RUBY's current cash is now $15M (was $230M) — a 93.4% year-over-year decrease. Pairing that YoY change with peer averages gives a clearer picture of whether Rubius Therapeutics is outperforming or lagging.

Tracking RUBY's current cash over time shows whether Rubius Therapeutics is scaling, shrinking, or reshaping that part of the business. The current reading is $15M That compares with $230M in the prior-year period — down 93.4% year over year. Multi-quarter patterns matter more than any single print, which is why this page emphasizes history and peer comparison charts.

Besides this current cash page, Stockcircle has Rubius Therapeutics's full stock overview, other financial metrics, insider and congress trade tabs, and tools to follow the stock. Together they help you connect current cash (currently $15M) with ownership activity and broader fundamentals.

Rubius Therapeutics's current cash is $15M; compare it with other Healthcare names on the peer chart. Typical ranges vary by sub-industry, so always sanity-check against the closest competitors, not just the whole sector bucket.